OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Indole Alkaloids, Synthetic Dimers and Hybrids with Potential In Vivo Anticancer Activity
Feng Song, Yunqiang Bian, Jing Liu, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 21, Iss. 5, pp. 377-403
Closed Access | Times Cited: 22

Showing 22 citing articles:

Naturally derived indole alkaloids targeting regulated cell death (RCD) for cancer therapy: from molecular mechanisms to potential therapeutic targets
Rui Qin, Feng‐Ming You, Qian Zhao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 63

Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers
Zhi Xu, Yafei Zhuang, Qingtai Chen
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115495-115495
Closed Access | Times Cited: 28

The current scenario of naturally occurring indole alkaloids with anticancer potential
Juntao Song, Bo Zhang, Ming Li, et al.
Fitoterapia (2023) Vol. 165, pp. 105430-105430
Closed Access | Times Cited: 23

What is the role of microbial biotechnology and genetic engineering in medicine?
Fernando Santos‐Beneit
MicrobiologyOpen (2024) Vol. 13, Iss. 2
Open Access | Times Cited: 13

Current status of carbazole hybrids as anticancer agents
Gangqiang Wang, Shaofa Sun, Hua Guo
European Journal of Medicinal Chemistry (2021) Vol. 229, pp. 113999-113999
Closed Access | Times Cited: 51

Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure–activity relationship, and mechanisms of action (2019–2021)
Lian‐Shun Feng, Wen‐Qi Su, Jin‐Bo Cheng, et al.
Archiv der Pharmazie (2022) Vol. 355, Iss. 6
Closed Access | Times Cited: 35

Bisindole natural products: A vital source for the development of new anticancer drugs
Mengwei Xu, Rui Peng, Min Qing, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114748-114748
Closed Access | Times Cited: 34

Synthesis, Antibacterial Activity, and Mechanisms of Novel Indole Derivatives Containing Pyridinium Moieties
Hongde Li, Shang Wu, Xiong Yang, et al.
Journal of Agricultural and Food Chemistry (2022) Vol. 70, Iss. 39, pp. 12341-12354
Closed Access | Times Cited: 29

Indole alkaloids from marine resources: Understandings from therapeutic point of view to treat cancers
Fahadul Islam, Zerrouki Dehbia, Mehrukh Zehravi, et al.
Chemico-Biological Interactions (2023) Vol. 383, pp. 110682-110682
Closed Access | Times Cited: 13

Development of indole hybrids for potential lung cancer treatment - part II
Shanshan Huang, Zhi Xu, Yafei Zhuang
Future Medicinal Chemistry (2025), pp. 1-17
Closed Access

Access to Polycyclic Indole-3,4-Fused Nine-Membered Ring via Cascade 1,6-Hydride Transfer/Cyclization
Shuo Yang, Xiao‐De An, Bin Qiu, et al.
Organic Letters (2021) Vol. 23, Iss. 23, pp. 9100-9105
Closed Access | Times Cited: 24

The therapeutic potential of indole hybrids, dimers, and trimers against drug‐resistant ESKAPE pathogens
Ye Qiongxian, Jun Deng, Zhenfeng Zhang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access | Times Cited: 3

Synthesis and photodynamic activity of new 5‐[(E)‐2‐(3‐alkoxy‐1‐phenyl‐1H‐pyrazol‐4‐yl)ethenyl]‐2‐phenyl‐3H‐indoles
Gabrielė Varvuolytė, Eva Řezníčková, Aurimas Bieliauskas, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Open Access | Times Cited: 3

Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency
Yuan Jiang Pan, Haodong Hou, Bo Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115879-115879
Closed Access | Times Cited: 8

A biomimetic approach to lycogarubin C, lynamicin D and related analogues
Wenxue Li, Sheng Liu
Organic & Biomolecular Chemistry (2024) Vol. 22, Iss. 13, pp. 2558-2561
Closed Access | Times Cited: 2

Concise Construction of 1‐Sulfonyl‐1H‐indoles Using Solid Calcium Carbide as a Surrogate of Gaseous Acetylene
Wei Chen, Guorui Li, Fei Wen, et al.
ChemistrySelect (2023) Vol. 8, Iss. 5
Closed Access | Times Cited: 6

1,6-Hydride Transfer-Enabled [6 + 1] Annulation to Access Polycyclic 3,4-Fused Azepinoindoles
Xiao‐De An, Zhong Lin Wang, Yao‐Bin Shen, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 13, pp. 8791-8801
Closed Access | Times Cited: 6

Identification potential biomarkers for diagnosis, and progress of breast cancer by using high-pressure photon ionization time-of-flight mass spectrometry
Jiao Zhang, Xixi He, Xuhui Guo, et al.
Analytica Chimica Acta (2024) Vol. 1320, pp. 342883-342883
Closed Access | Times Cited: 1

Recent Updates on the Anticancer Activity of Quinoxaline Hybrids (Jan. 2017-Jan. 2022)
Lian‐Shun Feng, Chuan Gao, Fa-Wu Liu, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 1426-1441
Closed Access | Times Cited: 7

The anti‐breast cancer potential of indole/isatin hybrids
Ruo Wang, Renhong Huang, Yaofeng Yuan, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 11
Closed Access | Times Cited: 3

HOAc catalyzed three-component reaction for the synthesis of 3,3′-(arylmethylene)bis(1H-indoles)
Heng Li, Yan Zhu, Cong Jiang, et al.
Organic & Biomolecular Chemistry (2022) Vol. 20, Iss. 16, pp. 3365-3374
Closed Access | Times Cited: 2

Page 1

Scroll to top